Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA May Prosecute More Pharmaceutical Execs
Pharmalot
Thursday, March 4, 2010 - 11:40am
tags:
FDA, pharmaceutical executives
Merck Presents Positive Data
Yahoo/Zacks.com
Thursday, March 4, 2010 - 11:39am
tags:
Merck, Asmanex
La Jolla Pharma to be delisted after merger flop
Fierce Biotech
Thursday, March 4, 2010 - 9:50am
tags:
La Jolla Pharmaceutical
Merck/GTX: If a Collaboration Fails in the Forest, Does it Make a Sound?
InVivo
Thursday, March 4, 2010 - 9:48am
tags:
Merck, GTx, ostarine, licensing
Want A Good Sales Rep? Poach From Your Rival
Pharmalot
Thursday, March 4, 2010 - 9:43am
tags:
sales reps
Inspire posts smaller loss as Azasite sales rise
Yahoo/AP
Thursday, March 4, 2010 - 9:41am
tags:
Inspire, earnings, Azasite
Bristol sets baseline for profits post-Plavix
Yahoo/Reuters
Thursday, March 4, 2010 - 8:29am
tags:
Bristol-Myers Squibb, Plavix, guidance
Astellas CEO: A logical idealist
Fierce Pharma
Thursday, March 4, 2010 - 7:16am
tags:
Astellas, Pharma CEOs, Masafumi Nogimori, OSI Pharmaceuticals, M&A
Rogue Analyst Provides Questionable Fodder for Dendreon Conspiracy Theorists
BNET Pharma
Thursday, March 4, 2010 - 7:15am
tags:
Provenge, prostate cancer, Dendreon
Sanofi's Cancer Drug May Set New Standard
TheStreet.com
Thursday, March 4, 2010 - 7:13am
tags:
Sanofi, cabazitaxel, Medivation, JNJ, Provenge, Dendreon, prostate cancer
Why It's Time to Sell Cephalon
Seeking Alpha
Wednesday, March 3, 2010 - 9:38pm
tags:
Cephalon
Questcor: Biotech Winner
TheStreet.com
Wednesday, March 3, 2010 - 6:04pm
tags:
Questcor Pharmaceuticals
FDA Sees Increasing Number Of Insulin Pump Problems
WSJ Online
Wednesday, March 3, 2010 - 5:36pm
tags:
FDA, insulin pumps, Roche, Medtronic
Drug developers show little reaction to Obama push on health care reform
Yahoo/AP
Wednesday, March 3, 2010 - 5:01pm
tags:
healthcare reform, Abbott Laboratories, Amgen, AstraZeneca
Will Andreotti Merge Bristol-Myers Squibb?
Pharmalot
Wednesday, March 3, 2010 - 4:59pm
tags:
Bristol-Myers Squibb, M&A, Eli Lilly
Bullish on Pozen
Yahoo/Zacks.com
Wednesday, March 3, 2010 - 4:57pm
tags:
Pozen, GSK, AstraZeneca
Pharma reports 26,000 layoffs in 2010
Fierce Pharma
Wednesday, March 3, 2010 - 12:04pm
tags:
layoffs
Covidien launches generic version of Actiq
Yahoo/AP
Wednesday, March 3, 2010 - 12:00pm
tags:
Covidien, generics, Actiq
Pfizer’s Jeff Kindler Gets A Hefty Raise
Pharmalot
Wednesday, March 3, 2010 - 11:59am
tags:
Pfizer, Jeff Kindler, executive pay, Pharma CEOs
The Incompetent Monopolist: Genzyme's Drug Screwups Invite Attacks by Shire, Pfizer
BNET Pharma
Wednesday, March 3, 2010 - 11:57am
tags:
Genzyme, Shire, Pfizer, Gaucher disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.